Indolyl-3-glyoxylic acid derivatives serving as antitumor agents

摘要

The invention relates to the use of N-substituted indol-3- glyoxylamides of general formula 1 for treating tumors, in particular, in cases of drug resistance and metastatic carcinoma, and as angiogenesis inhibitors having distinctly fewer side effects, in particular, distinctly lower neurotoxicity. The invention also relates to medicaments containing the inventive compounds.